ArticleJournal of endocrinological investigation2022
Increased odds ratio for erectile dysfunction in COVID-19 patients.
Article in Journal of endocrinological investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and risk factors of erectile dysfunction in COVID-19 patients: a systematic review and meta-analysis.Journal of endocrinological investigation · 2023Pooled it
- Expression of SARS-CoV-2 entry receptor ACE2 in human brain and its association with Alzheimer's disease and COVID-19.Molecular psychiatry · 2025Review
- Causal associations between COVID-19 and erectile dysfunction: a Mendelian randomization study.The Journal of international medical research · 2024Article
- Prior COVID-19 infection associated with increased risk of newly diagnosed erectile dysfunction.International journal of impotence research · 2024Article
- Comment on: Prior COVID-19 infection associated with increased risk of newly diagnosed erectile dysfunction.International journal of impotence research · 2024Article
- Galectin-3 is involved in inflammation and fibrosis in arteriogenic erectile dysfunction via the TLR4/MyD88/NF-κB pathway.Cell death discovery · 2024Article
- The indicative effects of apolipoproteins on organic erectile dysfunction: bridging Mendelian randomization and case-control study.Frontiers in endocrinology · 2024Article
- Role of Nutraceuticals in Treating Erectile DysfunctionCurrent pharmaceutical biotechnology · 2024Review
- The effects of non-andrological medications on erectile dysfunction: a large single-center retrospective study.Journal of endocrinological investigation · 2023Article
- COVID-19 vaccination does not affect male sexual functions.Reproductive biology and endocrinology : RB&E · 2023Article
- Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study.Journal of endocrinological investigation · 2023Article
- Updates in the pathophysiology of COVID-19 infection in male reproductive and sexual health: a literature review.Frontiers in endocrinology · 2023Review
- Impact of the COVID-19 Pandemic on the Female Sexual Function Index and Female Behavioral Changes: A Cross-Sectional Survey Study in Thailand.International journal of environmental research and public health · 2022Article
- Mental and Sexual Health of Men in Times of COVID-19 Lockdown.International journal of environmental research and public health · 2022Article
- Article
- Erectile dysfunction and premature ejaculation: a continuum movens supporting couple sexual dysfunction.Journal of endocrinological investigation · 2022Review
- Impact of COVID-19 on male urogenital health: Success of vaccines.Drug discovery today · 2022Review
- A Prospective Cohort Study of COVID-19 Vaccination, SARS-CoV-2 Infection, and Fertility.American journal of epidemiology · 2022Article
- Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body.International journal of molecular sciences · 2022Review
- Post-COVID Erectile Dysfunction: The Exercise May Be a Good Considered Complementary Choice.American journal of men's healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeErectile dysfunction and COVID-19 share similar risk factors, including vascular disruption of integrity, cytokine release, cardiovascular disease, diabetes and obesity. The aim of this study was to investigate the association between erectile dysfunction and COVID-19 patients.
methodsOdds ratio for erectile dysfunction in patients with a history of COVID-19 with and without comorbidities were calculated using a patients' registry platform i2b2. ICD-10 diagnoses codes were accessed for queries and data were analyzed using logistic regression.
resultsPatients with COVID-19 were 3.3 times more likely to have erectile dysfunction with 95% CI (2.8, 3.8). The association became stronger with odds ratio 4.8 (95% CI (4.1, 5.7)) after adjusting for age groups. The odds ratio remained the same after adjusting for smoking status with 3.5 (95% CI (3.0, 4.1)). After adjusting for race, COVID-19 patients were 2.6 (95% CI (2.2, 3.1)) times more likely to have erectile dysfunction. The odds ratio were 1.6, 1.8, 1.9 and 2.3 after adjusting for respiratory disease, obesity, circulatory disease and diabetes, respectively.
conclusionCOVID-19 and erectile dysfunction are strongly associated even after adjustment for known risk factors and demographics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.